Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.63%
#4 aPriori aPriori +192.70%
#5 Bedrock Bedrock +77.76%
#6 Cysic Cysic +52.73%
#7 Prom Prom +46.24%
#8 Playnance Playnance +34.82%
#9 Bitway Bitway +27.08%
#10 COTI COTI +24.13%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc.

TMBR
Classifica tra le azioni #42059
Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the research, development, and market introduction of treatments for rare dermatological conditions. The company's key product candidates include: TMB-001, a patented topical isotretinoin formulation, which has successfully completed Phase 2b clinical trials. It is designed to address moderate to severe forms of Congenital Ichthyosis (CI), a group of uncommon genetic disorders affecting skin keratinization. TMB-002, a proprietary topical rapamycin, currently undergoing Phase 2b clinical trials. This therapy targets facial angiofibroma associated with Tuberous Sclerosis Complex, a complex genetic disorder characterized by the growth of benign tumors in multiple organs. TMB-003, a unique Sitaxsentan formulation functioning as a selective endothelin-A receptor antagonist, which is in preclinical development for various sclerotic skin diseases. Additionally, through a licensing agreement with AFT Pharmaceuticals Limited, Timber Pharmaceuticals is advancing two topical minocycline therapies: BPX-01, now in Phase 3 development for treating inflammatory lesions of acne vulgaris. BPX-04, which is prepared for Phase 3 trials, targeting papulopustular rosacea. Founded in 2019, Timber Pharmaceuticals is headquartered in Basking Ridge, New Jersey.
Prezzo delle azioni
$0.0101
Ultima sincronizzazione: 2023-12-26
Capitalizzazione di mercato
$5.32K
Variazione (1 giorno)
741.67%
Variazione (1 anno)
0.00%
Paese
US
Scambia Timber Pharmaceuticals, Inc. (TMBR)

Categoria

Healthcare
Il prezzo TMBR con la capitalizzazione del mercato della B
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
TMBR
$0.0101
Capitalizzazione di mercato di Timber Pharmaceuticals, Inc.(TMBR)
Capitalizzazione di mercato: $5.32K
A partire dal August 2026, Timber Pharmaceuticals, Inc. ha una capitalizzazione di mercato pari a $5.32K. Questo rende Timber Pharmaceuticals, Inc. la 42059th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Timber Pharmaceuticals, Inc. dal 2014 al 2026
TMBR in paragone con la classifica dei più popolari stocks
Il prezzo per TMBR Attivo B Capitalizzazione del mercato a B Risultati
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$10,227,038 $5.32K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +101,257,803,053.34%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$8,403,338 $5.32K
Apple Inc. Apple Inc.
AAPL
$4.423T +83,201,368,693.29%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$7,903,663 $5.32K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +78,254,084,322.11%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$6,959,394 $5.32K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +68,904,895,245.87%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$5,492,612 $5.32K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +54,382,301,214.11%